Viloxazine: An Assessment of its Potential Rapid Antidepressant Action and Unwanted Effects

References

• Amaducci L. MuIticentrestudieswithviloxazine(Vicilan). J.Int.Med.Res. 1975; 3: 95–96, Suppl. 31. Amaducci L. MuIticentrestudieswithviloxazine(Vicilan). J.Int.Med.Res. 1975; 3: 95–96, Suppl. 3
   Google Scholar
• Bayliss P. F. C, Duncan S. M. The clinical pharmacology of viloxazine hydrochloride - a new antidepressant of novel chemical structure. Br. J. Clin. Pharmacol. 1974; 1: 431–437, J. Guy Edwards2. Bayliss P. F. C, Duncan S. M. The clinical pharmacology of viloxazine hydrochloride - a new antidepressant of novel chemical structure. Br. J. Clin. Pharmacol. 1974; 1: 431–437, J. Guy Edwards
   PubMed Web of Science ®Google Scholar
• Bayliss P. F. C, Dewsbury A. R., Donald J. F., Harcup J. W., Mayer M., Million R., Molla A. L., Murphy J. E., Plant B., Shaoul E. A double-blind controlled trial of ‘Vivalan’ (viloxazine hydrochloride) and imipramine hydrochloride in the treatment of depression in general practice. J. Int. Med. Res. 1974; 2: 260–2643. Bayliss P. F. C, Dewsbury A. R., Donald J. F., Harcup J. W., Mayer M., Million R., Molla A. L., Murphy J. E., Plant B., Shaoul E. A double-blind controlled trial of ‘Vivalan’ (viloxazine hydrochloride) and imipramine hydrochloride in the treatment of depression in general practice. J. Int. Med. Res. 1974; 2: 260–264
   Web of Science ®Google Scholar
• Bayliss P. F. C, Harcup J. W., Mayer M., Million R., Murphy J. E., Plant B., Shaoul E. An open study of two dose levels of ‘Vivalan’ (viloxazine hydrochloride, ICI 58 834) in depression in general practice. J. Int. Med. Res. 1974; 2: 253–2594. Bayliss P. F. C, Harcup J. W., Mayer M., Million R., Murphy J. E., Plant B., Shaoul E. An open study of two dose levels of ‘Vivalan’ (viloxazine hydrochloride, ICI 58 834) in depression in general practice. J. Int. Med. Res. 1974; 2: 253–259
   Web of Science ®Google Scholar
• Beecher H. K. The powerful placebo. J.A.M.A. 1955; 159: 1602–16065. Beecher H. K. The powerful placebo. J.A.M.A. 1955; 159: 1602–1606
   PubMed Web of Science ®Google Scholar
• Bereen F. J. A new potential antidepressive. Lancet 1973; 1: 379–3806. Bereen F. J. A new potential antidepressive. Lancet 1973; 1: 379–380
   PubMed Web of Science ®Google Scholar
• Blashki T. G., Mowbray R., Davies B. Controlled trial of amitriptyline in general practice. Br. Med. J. 1971; 1: 133–1387. Blashki T. G., Mowbray R., Davies B. Controlled trial of amitriptyline in general practice. Br. Med. J. 1971; 1: 133–138
   PubMed Web of Science ®Google Scholar
• Breinová V., Adam K., Chapman K., Oswald I., Thomson J. Viloxazine, sleep and subjective feelings. Psychopharmacologia 1977, In press8. Breinová V., Adam K., Chapman K., Oswald I., Thomson J. Viloxazine, sleep and subjective feelings. Psychopharmacologia 1977, In press
   Web of Science ®Google Scholar
• Brion S. Open studies with viloxazine (Vivalan). J. Int. Med. Res. 1975; 3: Suppl. 3, 87–919. Brion S. Open studies with viloxazine (Vivalan). J. Int. Med. Res. 1975; 3: Suppl. 3, 87–91
   Web of Science ®Google Scholar
• Case D. E. Gas-liquid chromatographic estimation in blood of ICI 58,834. J. Pharm. Pharmacol 1973; 25: 800–80210. Case D. E. Gas-liquid chromatographic estimation in blood of ICI 58,834. J. Pharm. Pharmacol 1973; 25: 800–802
   PubMed Web of Science ®Google Scholar
• Edwards J. G. Unwanted effects of psychotropic drugs. I. Some general considerations. Practitioner 1977; 218: 556–56211. Edwards J. G. Unwanted effects of psychotropic drugs. I. Some general considerations. Practitioner 1977; 218: 556–562
   PubMedGoogle Scholar
• Edwards J. G. Convulsive seizures and viloxazine. Br. Med. J. 1977; 2: 96–9712. Edwards J. G. Convulsive seizures and viloxazine. Br. Med. J. 1977; 2: 96–97
   PubMed Web of Science ®Google Scholar
• Edwards J. G., Ollerenshaw D. P. Daledalin tosylate: a controlled trial in depressive illness. Curr. Med. Res. Opin. 1974; 2: 305–31213. Edwards J. G., Ollerenshaw D. P. Daledalin tosylate: a controlled trial in depressive illness. Curr. Med. Res. Opin. 1974; 2: 305–312
   PubMed Web of Science ®Google Scholar
• Floru Von-L., Czarny G., Tegeler J. Double-blind study with the novel antidepressant viloxazine versus imipramine in 50 in-patients. Arzneim. Forsch. 1976; 26: 1170–117114. Floru Von-L., Czarny G., Tegeler J. Double-blind study with the novel antidepressant viloxazine versus imipramine in 50 in-patients. Arzneim. Forsch. 1976; 26: 1170–1171
   PubMed Web of Science ®Google Scholar
• Greenwood D. T. Animal pharmacology of viloxazine (Vivalan). J. Int. Med. Res. 1975; 3: Suppl. 3, 18–2815. Greenwood D. T. Animal pharmacology of viloxazine (Vivalan). J. Int. Med. Res. 1975; 3: Suppl. 3, 18–28
   Web of Science ®Google Scholar
• Hamilton M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry 1960; 23: 56–6116. Hamilton M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry 1960; 23: 56–61
   PubMed Web of Science ®Google Scholar
• Hartman E., Cravens J. The effects of long-term administration of psychotropic drugs on human sleep. III. The effects of amitriptyline. Psychopharmacologia 1973; 33: 185–20217. Hartman E., Cravens J. The effects of long-term administration of psychotropic drugs on human sleep. III. The effects of amitriptyline. Psychopharmacologia 1973; 33: 185–202
   PubMedGoogle Scholar
• Magnus R. V. A placebo controlled trial of viloxazine with and without tranquillisers in depressive illness. J. Int. Med. Res. 1975; 3: 207–21318. Magnus R. V. A placebo controlled trial of viloxazine with and without tranquillisers in depressive illness. J. Int. Med. Res. 1975; 3: 207–213
   PubMed Web of Science ®Google Scholar
• Mahapatra S. B. Short term effects of viloxazine (Vivalan) compared with placebo in depression: a double-blind study. J. Int. Med. Res. 1975; 3: Suppl. 3, 70–7419. Mahapatra S. B. Short term effects of viloxazine (Vivalan) compared with placebo in depression: a double-blind study. J. Int. Med. Res. 1975; 3: Suppl. 3, 70–74
   Web of Science ®Google Scholar
• Mallion K. B., Todd A. H., Turner R. W., Bainbridge J. G., Greenwood D. T., Madinaveitia J., Somerville A. R., Whittle B. A. 2-(2-ethoxyphenoxymethyl) tetrahydro-1,4-oxazine hydrochloride, a potential psychotropic agent. Nature 1972; 238: 15720. Mallion K. B., Todd A. H., Turner R. W., Bainbridge J. G., Greenwood D. T., Madinaveitia J., Somerville A. R., Whittle B. A. 2-(2-ethoxyphenoxymethyl) tetrahydro-1,4-oxazine hydrochloride, a potential psychotropic agent. Nature 1972; 238: 157
   PubMed Web of Science ®Google Scholar
• Council Medical Research. Clinical trial of the treatment of depressive illness. A report to the Medical Research Council by its Clinical Psychiatry Committee. Br. Med. J. 1965; 1: 881–88621. Council Medical Research. Clinical trial of the treatment of depressive illness. A report to the Medical Research Council by its Clinical Psychiatry Committee. Br. Med. J. 1965; 1: 881–886
   PubMed Web of Science ®Google Scholar
• Murphy J. E. Viloxazine (Vivalan) - general practitioner group studies. J. Int. Med. Res. 3, Suppl 1975; 3: 115–11922. Murphy J. E. Viloxazine (Vivalan) - general practitioner group studies. J. Int. Med. Res. 3, Suppl 1975; 3: 115–119
   Web of Science ®Google Scholar
• Oswald I., Brezinova V., Dunleavy D. L. F. On the slowness of action of tricyclic antidepressant drugs. Br. J. Psychiatry 1972; 120: 673–67723. Oswald I., Brezinova V., Dunleavy D. L. F. On the slowness of action of tricyclic antidepressant drugs. Br. J. Psychiatry 1972; 120: 673–677
   PubMed Web of Science ®Google Scholar
• Ouri P. Additional studies - Finland. J. Int. Med. Res. 1975; 3: Suppl. 3, 9924. Ouri P. Additional studies - Finland. J. Int. Med. Res. 1975; 3: Suppl. 3, 99
   Web of Science ®Google Scholar
• Pichot P., Guelfi J., Dreyful J. F. A controlled multicentre therapeutic trial of viloxazine (Vivalan). J. Int. Med. Res. 1975; 3: Suppl. 3, 80–8625. Pichot P., Guelfi J., Dreyful J. F. A controlled multicentre therapeutic trial of viloxazine (Vivalan). J. Int. Med. Res. 1975; 3: Suppl. 3, 80–86
   Web of Science ®Google Scholar
• Snaith R. P., Ahmed S.R, Mehta S., Hamilton M. Assessment of severity of primary depressive illness. Psychol. Med. 1971; 1: 143–14926. Snaith R. P., Ahmed S.R, Mehta S., Hamilton M. Assessment of severity of primary depressive illness. Psychol. Med. 1971; 1: 143–149
   PubMed Web of Science ®Google Scholar
• Tsegos I. K., Ekdawi M. Y. A double-blind controlled study of viloxazine and imipramine in depression. Curr. Med. Res. Opin. 1974; 2: 455–46027. Tsegos I. K., Ekdawi M. Y. A double-blind controlled study of viloxazine and imipramine in depression. Curr. Med. Res. Opin. 1974; 2: 455–460
   PubMed Web of Science ®Google Scholar